JOFOC for New Born Screening Transitional Research Network

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to exercise a 6-month option contract modification with the incumbent contractor, American College of Medical Genetics and Genomics, 7101 Wisconsin Ave #1101, Bethesda, MD 20814. The purpose of the contract is to maintain, administer and enhance the Newborn Screening Translational Research Network (NBSTRN) and provide the technical, regulatory, scientific and administrative support related to NBSTRN . The proposed action is a modification to an existing contract. This modification will extend the current period of performance by 6 months in accordance with FAR 52.217-8 which is cited in the current contract. The period of Performance would be extended by 6 months from September 26, 2023, to March 25, 2023. This extension will allow the contractor to complete transitional activities as specified in the Statement of Work. ACMG currently performs the following activities: Maintain, administer, and enhance an efficient and reliable virtual repository of residual dried bloodspots (VRDBS). Maintain, administer and enhance a laboratory performance database. Maintain and enhance a network of centralized and institutionally enabled infrastructure to support the capture and managed storage of longitudinal clinical data from individuals following newborn screening, in the Longitudinal Pediatric Data Resource (LPDR). Maintain a data repository that securely houses long-term follow-up genomic data, materials metadata and key phenotypic data for subjects followed within the long- term follow-up dataset (LPDR). Establish, Maintain and Administer a web-based interactive resource related to the ethical, legal and social issues (ELSI) relevant to Newborn Screening for investigators. Facilitate, through collaborations with other Federal entities (e.g., National Library of Medicine, Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration (HRSA), relevant National Institutes of Health Institutes and Centers) and interested stakeholders, the development and use of common data elements and standardized language for newborn screening diseases and disorders that may benefit in the future from newborn screening. Support active and future newborn screening research projects, including pilot studies for conditions with the potential to be added to the RUSP. Facilitate the timely dissemination of research findings in the form of written publications, web-based materials, and presentations at newborn screening-related in- person or virtual meetings, such as the Association of Public Health Laboratories newborn screening symposium, on the activities to a variety of stakeholders. Establish working groups composed of scientific experts in the NBS field to provide input on topics relevant to NBSTRN functions. The Government intends to solicit the contract on a sole source basis under FAR 6.302-1 - Only One Responsible Source and no Other Supplies or Services will Satisfy Agency Requirements. This notice of intent is not a request for competitive proposals or a solicitation of offers. No solicitation document is available.. For information regarding this notice, contact Lola St John, Contracting Officer, via email to [email protected] .